- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Experimental Diabetes Research
Volume 2009 (2009), Article ID 912327, 8 pages
Vascular and Neural Dysfunctions in Obese Zucker Rats: Effect of AVE7688
1Department of Veterans Affairs Iowa City Health Care System, University of Iowa, Iowa City, IA 52246, USA
2Department of Internal Medicine, University of Iowa, Iowa City, IA 52246, USA
Received 3 February 2009; Accepted 12 May 2009
Academic Editor: Soroku Yagihashi
Copyright © 2009 Eric P. Davidson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [9 citations]
The following is the list of published articles that have cited the current article.
- Irina G. Obrosova, “Diabetic painful and insensate neuropathy: Pathogenesis and potential treatments,” Neurotherapeutics, vol. 6, no. 4, pp. 638–647, 2009.
- Lawrence Coppey, Eric Davidson, Bao Lu, Craig Gerard, and Mark Yorek, “Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice,” Neuropharmacology, vol. 60, no. 2-3, pp. 259–266, 2011.
- Eric P. Davidson, Lawrence J. Coppey, Amey Holmes, Brian Dake, and Mark A. Yorek, “Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications,” European Journal of Pharmacology, vol. 668, no. 3, pp. 497–506, 2011.
- Christine L. Oltman, Eric P. Davidson, Lawrence J. Coppey, Travis L. Kleinschmidt, Brian Dake, and Mark A. Yorek, “Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats,” European Journal of Pharmacology, vol. 650, no. 2-3, pp. 556–562, 2011.
- Eric P. Davidson, Lawrence J. Coppey, Brian Dake, and Mark A. Yorek, “Treatment of Streptozotocin-Induced Diabetic Rats with Alogliptin: Effect on Vascular and Neural Complications,” Experimental Diabetes Research, vol. 2011, pp. 1–7, 2011.
- Eric P. Davidson, Lawrence J. Coppey, Amey Holmes, and Mark A. Yorek, “Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats,” European Journal of Pharmacology, vol. 677, no. 1-3, pp. 180–187, 2012.
- Zsolt Bagi, Attila Feher, and James Cassuto, “Microvascular responsiveness in obesity: implications for therapeutic intervention,” British Journal of Pharmacology, vol. 165, no. 3, pp. 544–560, 2012.
- Lawrence Coppey, Bao Lu, Craig Gerard, and Mark A. Yorek, “Effect of inhibition of angiotensin-converting enzyme and/or neutral endopeptidase on neuropathy in high-fat-fed C57Bl/6J Mice,” Journal of Obesity, vol. 2012, 2012.
- T. Dylan Olver, Matthew W. McDonald, Kenneth N. Grise, Adwitia Dey, Matti D. Allen, Philip J. Medeiros, James C. Lacefield, Dwayne N. Jackson, Charles L. Rice, C. W. James Melling, Earl G. Noble, and J. Kevin Shoemaker, “Exercise training enhances insulin-stimulated nerve arterial vasodilation in rats with insulin-treated experimental diabetes,” American Journal of Physiology-Regulatory Integrative and Comparative Physi, vol. 306, no. 12, pp. R941–R950, 2014.